# FDA 483 - C.J. Labs, Inc. - September 25, 2019

Source: https://www.keypedia.com/records/483/cj-labs-inc/0dbaae0e-d973-496b-8def-8834aba1ea86

> FDA 483 for C.J. Labs, Inc. on September 25, 2019. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: C.J. Labs, Inc.
- Inspection Date: 2019-09-25
- Product Type: other
- Office Name: Office of Medical Device and Radiological Health Division II
- Summary: An FDA inspection of G&G Labs, Inc. in Miami, FL, from September 23-25, 2019, revealed a significant quality control deficiency. The firm failed to calibrate instruments and controls used in manufacturing and testing dietary supplements, including critical HPLC equipment. This indicates a systemic issue with ensuring the accuracy and precision of their testing processes.

## Related Officers

- [Lourdes Andujar](https://www.keypedia.com/people/lourdes-andujar/974f57ac-d5ee-4432-9fa7-a873145432ed)

Company: https://www.keypedia.com/companies/cj-labs-inc/a610497d-3e48-4c7c-a53c-a67cc5301b6a

Office: https://www.keypedia.com/offices/office-of-medical-device-and-radiological-health-division-ii/ae9bd439-479a-420d-9dd8-9fe1fc0863d6